Rite Aid Corp (RAD) 7.44 $RAD Adding A Few High Flyers

New Post Public Reply Private Reply Replies (0) Message Board

Mar 16, 2015 at 2:11 PM

Rite Aid Corp (RAD) 7.44 $RAD

Adding A Few High Flyers To A Growth Portfolio
Abba's Aces - at Seeking Alpha - Sun Mar 15, 1:01PM CDT

NFLX: 419.91 (-18.49), BIIB: 420.30 (+6.95), FB: 77.69 (-0.36), RAD: 7.44 (-0.01)

Expect Walgreens To Acquire Rite Aid
Brian Nichols - at Seeking Alpha - Sat Mar 14, 9:08AM CDT

WBA: 86.39 (+2.67), RAD: 7.44 (-0.01)

Rite Aid Should Not Abandon Its +UP Program
Brian Nichols - at Seeking Alpha - Sat Mar 14, 1:51AM CDT

RAD: 7.44 (-0.01)

Rite Aid Up 32.8% Since SmarTrend Uptrend Call (RAD)
Comtex SmarTrend(R) - Thu Mar 12, 5:01PM CDT
SmarTrend identified an Uptrend for Rite Aid (NYSE:RAD) on December 8th, 2014 at $5.67. In approximately 3 months, Rite Aid has returned 32.80% as of today's recent price of $7.53.
RAD: 7.44 (-0.01)

Rite Aid's New Harrisburg Store to Extend Wellness Program - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 11, 11:00AM CDT
Rite Aid (RAD) announced the introduction of a brand new outlet in Harrisburg.
HLF: 34.55 (-1.41), WBA: 86.39 (+2.67), CVS: 104.19 (+0.93), RAD: 7.44 (-0.01)

Rite Aid Announces Opening of New Store in Harrisburg, Pa.
Business Wire - Tue Mar 10, 8:00AM CDT
--Congressman Lou Barletta, Rite Aid Chairman and Chief Executive Officer John Standley and Rite Aid President and Chief Operating Officer Ken Martindale to Host Ribbon-Cutting Today at 10:30 a.m.
RAD: 7.44 (-0.01)

Better Buy: Rite Aid Corp. Versus CVS Health
Todd Campbell, The Motley Fool - Motley Fool - Tue Mar 10, 6:01AM CDT
An ever-aging and increasingly insured population means that prescription medicine volume is going to climb for years to come. Two of the companies that are perfectly positioned to profit from that tidal wave of baby boomer demand are Rite Aid...
CVS: 104.19 (+0.93), RAD: 7.44 (-0.01)

4 Big Stocks on Traders' Radars: Rite Aid, BlackBerry and More
at The Street - Tue Mar 10, 6:00AM CDT
Here's how to trade some of the most active stocks on the market right now.
WLL: 38.35 (-1.65), BBRY: 9.66 (-0.15), CTIC: 1.98 (+0.01), RAD: 7.44 (-0.01)

SmarTrend Watching for Potential Rebound in Shares of Rite Aid After 1.83% Loss
Comtex SmarTrend(R) - Mon Mar 09, 4:15PM CDT
Rite Aid (NYSE:RAD) traded in a range yesterday that spanned from a low of $7.40 to a high of $7.63. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $7.51 on volume of 27.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
RAD: 7.44 (-0.01)

Conns February Comps Down on Weather, Port Disruptions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 09, 3:03PM CDT
Conns (CONN) recently posted its sales data for the month of February, where total retail sales advanced 4.9% year over year to $95.4 million.
ZUMZ: 38.73 (+1.49), CONN: 26.97 (-0.42), GPS: 41.36 (+0.23), RAD: 7.44 (-0.01)

Zumiez Maintains Positive Comps Trend in February - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 09, 2:47PM CDT
Following a positive comps trend built in the trailing 11 months, Zumiez (ZUMZ) recently reported yet another month of impressive sales results.
ZUMZ: 38.73 (+1.49), CONN: 26.97 (-0.42), GPS: 41.36 (+0.23), RAD: 7.44 (-0.01)

Rite Aid's (RAD) Key Sales Metrics for February Rise 3.3% - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 09, 2:40PM CDT
Drugstore chain retailer, Rite Aid Corporation (RAD) came up with healthy sales results for the month of February.
HLF: 34.55 (-1.41), WBA: 86.39 (+2.67), CVS: 104.19 (+0.93), RAD: 7.44 (-0.01)

Gap's (GPS) February Sales Remain Soft, Comps Down 4% - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 09, 2:22PM CDT
Gap (GPS) continues with its disappointing comparable store sales (comps) performance.
ZUMZ: 38.73 (+1.49), CONN: 26.97 (-0.42), GPS: 41.36 (+0.23), RAD: 7.44 (-0.01)

Active Equities to Watch in the Consumer Staples Sector -- Rite Aid, CVS Health, Colgate-Palmolive, Kimberly-Clark, and Clorox
PR Newswire - Mon Mar 09, 8:50AM CDT
Editor Note: For more information about this release, please scroll to bottom.
CLX: 109.00 (+0.23), KMB: 106.49 (+0.70), CVS: 104.19 (+0.93), CL: 68.83 (+0.37), RAD: 7.44 (-0.01)

Rite Aid: February's Sales Report Wasn't All That Bad
Brent A. Miller - at Seeking Alpha - Sun Mar 08, 1:58AM CST

RAD: 7.44 (-0.01)

Rite Aid's February Sales Report Is Better Than You Think
Brian Nichols - at Seeking Alpha - Fri Mar 06, 11:25AM CST

RAD: 7.44 (-0.01)

Winter's Wrath Blasts Retailers, But Not These Stocks
at Investor's Business Daily - Thu Mar 05, 5:14PM CST
Retailers in general posted soft February sales gains, below forecasts, as severe winter weather patterns, delays from the West Coast port slowdown and foreign exchange headwinds dampened results. But even as winter's wrath sent shoppers into...
ZUMZ: 38.73 (+1.49), LB: 92.20 (+1.22), COST: 149.96 (+0.68), GPS: 41.36 (+0.23), AAPL: 124.21 (+0.62), BKE: 49.16 (+1.12), SMRT: 12.32 (-0.04), RAD: 7.44 (-0.01)

Here’s a Reason Rite Aid (RAD) Stock Fell Today
at The Street - Thu Mar 05, 3:05PM CST
Rite Aid (RAD) stock was lower today after the company issued its same-store-sales results for February, which increased year-over-year but slowed down from January.
CVS: 104.19 (+0.93), RAD: 7.44 (-0.01)

Sales growth decelerates at Rite Aid in February
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 8:07AM CST

RAD: 7.44 (-0.01)

Feb. Retail Sales Likely Hit By Weather, Port Woes
at Investor's Business Daily - Wed Mar 04, 2:59PM CST
Retailers likely saw soft February sales gains as harsh winter weather, the West Coast port slowdown and foreign exchange headwinds dragged down results. As of Wednesday, analysts were expecting February sales at stores open at least a year to rise...
LB: 92.20 (+1.22), COST: 149.96 (+0.68), GPS: 41.36 (+0.23), BKE: 49.16 (+1.12), SMRT: 12.32 (-0.04), RAD: 7.44 (-0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

HTX's Strategic Moves in Pakistan: A Crypto Frontier

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Machine Grabs Prime Dallas Property Amid Apartment Boom

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

AI-Driven Lumi Transforms Car Dealership Interactions

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Davos Healthcare Aims to Revolutionize Hospital Ratings

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

FJBio Boosts Antibody Discovery with Sapio AI

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

The Chemical Industry and EPA: A Broken System?

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...